A multicenter study demonstrates that impulse oscillometry, a non-invasive method for measuring lung function, is an effective tool for assessing respiratory health in extremely preterm infants.
A multicenter study demonstrates that impulse oscillometry, a non-invasive method for measuring lung function, is an effective tool for assessing respiratory health in extremely preterm infants.
Read More
The NIH-funded study aims to establish disease subtypes that would help predict longer-term cardiorespiratory outcomes early in the course of neonatal care.Â
Read More
This article will discuss the invasive and noninvasive therapy options available for NICU clinicians, including bCPAP, HFO, NIV and invasive ventilation—and the factors these clinicians must weigh when initializing therapy or when it becomes necessary to escalate respiratory support.
Read More
The model identified with 96% accuracy bronchopulmonary dysplasia in premature infants by analyzing their sleep breathing patterns.
Read More
This live biotherapeutic product, tested in mouse models, shows promise in addressing common pathways of lung disease progression.
Read More
A new study shows that early changes in blood proteins can predict bronchopulmonary dysplasia in preterm infants, enabling timely diagnosis and targeted treatments.
Read More
New research reveals how non-coding deletions in the FOXF1 gene lead to a rare, lethal infant lung disease, with implications for diagnosing and treating other pulmonary disorders.
Read More
The NIH grant will support the development of new treatment methods for lung diseases in premature infants using gene and cell therapy.
Read More
A study reveals that granulocyte colony-stimulating factor is a common pathological mechanism in both bronchopulmonary dysplasia and retinopathy of prematurity in premature infants, offering a new therapeutic target.
Read More
Here’s a look at best practices for initiating bubble CPAP, a noninvasive, low-cost therapy for preemies and infants in need of respiratory support.
Read More
Neonatal pulmonary disorders may require additional respiratory support beyond supplemental oxygen, such as nasal CPAP, HFNC, nasal BiPAP, NIPPV, nHFOV, or even NIV-NAVA.
Read More
A new article published in the American Journal of Physiology-Lung Cellular and Molecular Physiology suggests biological sex affects neonatal lung injury related to hyperoxia.
Read More
Hydrocortisone is no more effective than placebo at preventing bronchopulmonary dysplasia in infants born before the 30th week of pregnancy, according to NEJM published research.
Read More
The American Thoracic Society has published an official clinical practice guideline to help guide physicians who must determine when and how to treat infants, children and adolescents with post-prematurity respiratory disease (PPRD).
Read More
Noninvasive ventilation methods for respiratory distress syndrome have gained attention in recent years due to rising incidence of bronchopulmonary dysplasia in intubated infants.
Read More
Researchers in Germany have successfully developed a new protocol for identifying neonatal patients with bronchopulmonary dysplasia by the use of magnetic resonance imaging (MRI), according to a study published in Thorax.
Read MoreBronchopulmonary dysplasia (BPD), a fibrotic lung disease that affects preterm infants, has a tissue-repair signaling problem that is also seen in idiopathic pulmonary fibrosis, Vanderbilt University researchers report. The...
Read More
The incidence of bronchopulmonary dysplasia (BPD) continues to compromise long-term health in neonatal patients despite mechanical ventilation’s success in reducing infant mortality.Â
Read More
New devices are continuing the life-saving impact of bubble CPAP technology, which, since 1973, has saved thousands of newborns with severe respiratory illnesses.
Read More
A new study finds that the use of azithromycin may hold promise in treating Ureaplasma-colonized or infected premature infants to prevent bronchopulmonary dysplasia (BPD).
Read More
